Inventia Healthcare Limited

FDA Regulatory Profile

Inventia Healthcare Limited appears in FDA public data with 2 recalls, 0 510(k) clearances, 4 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0852-2026, Class II) was initiated on September 3, 2026.

Summary

Total Recalls
2
510(k) Clearances
0
Inspections
4
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0852-2026Class IIChlorthalidone Tablets, USP, 25 mg, 100 Tablets per bottle, Rx only, Manufactured by: Inventia HealtSeptember 3, 2026
D-0610-2026Class IIChlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: InvenJune 5, 2026